Clinical Trials in Cleveland

Showing 8821-8840 of 19,775 trials

Impact of Surgical Theater's Patient Engagement

NCT05334212

To evaluate usefulness of Surgical Theater's Patient Engagement 360VR platform in helping align patient expectations and improve patient satisfaction and understanding in spinal surgery consults.

Lumbar Spine SurgeriesCervical Spine Surgeries

University Hospitals Cleveland Medical Center7 participantsStarted Jan 2022

Cleveland, Ohio, United States • Middleburg Heights, Ohio, United States

COMPLETEDPhase 3< 1 mile

Clostridium Difficile Vaccine Efficacy Trial

NCT03090191

The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection. Participants in the study are adults 50 years of age and older, who are at risk of developing Clostridium difficile infection. The study will assess whether the vaccine prevents the disease, and whether it is safe and well tolerated. Each subject will receive 3 doses of Clostridium difficile vaccine or placebo and be followed for up to 3 years after vaccination for potential Clostridium difficile infection.

Clostridium Difficile Infection

Pfizer17,535 participantsStarted Mar 2017

Athens, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +423 more locations

Impact of Surgical Theater's Patient Engagement

Clostridium Difficile Vaccine Efficacy Trial

Find Trials by Condition in Cleveland

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies

SLSMDS Natural History Study

Validation of a Salivary miRNA Diagnostic Test for ASD

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML)

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)

Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens

Improving Quality by Maintaining Accurate Problems in the EHR

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Web-based Implementation for the Science of Enhancing Resilience Study

Peripheral Nerve Stimulation Therapy for Atrial Fibrillation